Erasca, Inc. (ERAS) Earnings History
Annual and quarterly earnings data from 2019 to 2024
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export ERAS earnings history in CSV or JSON format
Free sign-in required to download data
Erasca, Inc. (ERAS) Earnings Overview
As of February 28, 2026, Erasca, Inc. (ERAS) reported trailing twelve-month net income of -$128M, reflecting +0.2% year-over-year growth. The company earned $-0.45 per diluted share over the past four quarters.
Looking at the long-term picture, ERAS's historical earnings data spans multiple years. The company achieved its highest annual net income of -$12M in fiscal 2019.
Erasca, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to industry peers including RVMD (-$1.13B net income), INCY ($1.29B net income, 0.3% margin), GMAB ($6.57B net income, 0.4% margin), ERAS has comparable earnings metrics. Compare ERAS vs RVMD →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
6 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$162M | -29.3% | -$180M | $-0.69 | - | - |
| 2023 | -$125M | +48.5% | -$142M | $-0.83 | - | - |
| 2022 | -$243M | -97.8% | -$247M | $-1.99 | - | - |
| 2021 | -$123M | -20.8% | -$125M | $-1.03 | - | - |
| 2020 | -$102M | -744.4% | -$109M | $-0.85 | - | - |
| 2019 | -$12M | - | -$13M | $-0.10 | - | - |
See ERAS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ERAS Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ERAS vs AGIO
See how ERAS stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is ERAS growing earnings?
ERAS EPS of $-0.45 reflects slowing growth at +0.2%, below the 5-year CAGR of N/A. TTM net income is $-128M. Expansion rate has moderated.
What are ERAS's profit margins?
Erasca, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are ERAS's earnings?
ERAS earnings data spans 2019-2024. The current earnings trend is +0.2% YoY. Historical data enables comparison across business cycles.